Randomized dose-escalation designs for drug combination cancer trials with immunotherapy

October 29, 2018, by Pamela Forster

Mozgunov, p., Jaki, T. & Paoletti, X. (2018), Journal of Biopharmaceutical Statistics.

Subgroup identification in clinical trials via the predicted individual treatment effect

October 24, 2018, by Pamela Forster

Ballarini, N., Rosenkranz, G., Jaki, T., König, F. & Posch, M. (2018), PLOS ONE

Quantifying the association between progression‐free survival and overall survival in oncology trials using Kendall’s Tau

October 22, 2018, by Pamela Forster

Weber, E & Titman, A (2018). Statistics in Medicine

Bayesian knowledge integration for an in vitro–in vivo correlation model

October 4, 2018, by Pamela Forster

Erhardt, E., Ursino, M., Biewenga, J & Gasparini, M (2018), Biometrical Journal

A benchmark for dose finding studies with continuous outcomes

August 29, 2018, by Pamela Forster

Mozgunov, P., Jaki, T. & Paoletti, X (2018) Biostatistics

Vradi, E., Jaki, T., Vonk, R. & Brannath, W. (2018) A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay. Statistical Methods in Medical Research

August 10, 2018, by Pamela Forster

Mozgunov, P. & Jaki, T. (2018) An information-theoretic Phase I/II design for molecularly targeted agents that does not require an assumption of monotonicity. Journal of the Royal Statistical Society: Series C (Applied Statistics)

, by Pamela Forster

Nhacolo, A. & Brananth, W. (2018) Interval and point estimation in adaptive Phase II trials with binary endpoint. Statistical Methods in Medical Research

, by Pamela Forster

Saint-Hilary, G., Robert, V., Gasparini, M., Jaki, T & Mozgunov, P. (2018) A novel measure of drug benefit–risk assessment based on Scale Loss Score. Statistical Methods in Medical Research

, by Pamela Forster

La Gamba, F., Jacobs, T., Geys, H., Ver Donck, L. & Faes, C. (2018) A Bayesian K‐PD model for synergy: A case study

, by Pamela Forster